MAQS has advised Mofast AB (publ) on the sale of a property portfolio worth SEK 697 million

Mofast AB (publ) ("Mofast"), listed on the Spotlight Stock Market, has entered into a share purchase agreement with Episurf Medical AB (publ) ("Episurf"), listed on the Nasdaq Stockholm, regarding the sale of 36 properties with an underlying property value totalling SEK 697 million, before deduction of deferred tax.

The property portfolio consists of properties within social infrastructure, mainly LSS housing facilities, but also includes residential properties.

The preliminary purchase price of SEK 77 million will be settled through a private placement of Class B shares in Episurf at a subscription price of SEK 0.045 per share. In addition, Episurf will assume an intra-group debt to Mofast of approximately SEK 164.5 million, which will be settled through two convertible instruments, convertible into Class B shares in Episurf, bringing the total consideration to Mofast to approximately SEK 241.5 million. Mofast will remain as the property manager for the properties sold during an interim period in accordance with a separate agreement. The formal closing of the transaction is expected to take place during the second quarter of 2026.

MAQS advised Mofast through Jonas Blomquist (lead partner), Philip Lagerström and Richard Fiskesund.